Xeris Pharmaceuticals
XERS
#6686
Rank
C$0.74 B
Marketcap
$5.02
Share price
2.35%
Change (1 day)
81.35%
Change (1 year)

Earnings for Xeris Pharmaceuticals (XERS)

Earnings in 2024 (TTM): -C$48.38 Million

According to Xeris Pharmaceuticals's latest financial reports the company's current earnings are C$0.18 Billion. In 2023 the company made an earning of -C$53.12 Million, an increase over its 2022 earnings that were of -C$0.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Xeris Pharmaceuticals from 2017 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$48.38 Million-8.92%
2023 -C$53.12 Million-54.31%
2022 -C$0.12 Billion-30.11%
2021 -C$0.17 Billion43.37%
2020 -C$0.12 Billion-32.21%
2019 -C$0.18 Billion106.61%
2018 -C$82.84 Million116.69%
2017 -C$38.23 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.2 Billion 276.23%๐Ÿ‡บ๐Ÿ‡ธ USA